Cite
A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.
MLA
Hermanns, Thomas, et al. “A Noninvasive Urine-Based Methylation Biomarker Panel to Detect Bladder Cancer and Discriminate Cancer Grade.” Urologic Oncology, vol. 38, no. 6, June 2020, p. 603.e1-603.e7. EBSCOhost, https://doi.org/10.1016/j.urolonc.2020.01.007.
APA
Hermanns, T., Savio, A. J., Olkhov-Mitsel, E., Mari, A., Wettstein, M. S., Saba, K., Bhindi, B., Kuk, C., Poyet, C., Wild, P. J., Noon, A., Bashir, S., Juvet, T., Rendon, R. A., Waltregny, D., van der Kwast, T., Finelli, A., Kulkarni, G. S., Fleshner, N. E., & Lo, K. (2020). A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade. Urologic Oncology, 38(6), 603.e1-603.e7. https://doi.org/10.1016/j.urolonc.2020.01.007
Chicago
Hermanns, Thomas, Andrea J. Savio, Ekaterina Olkhov-Mitsel, Andrea Mari, Marian S. Wettstein, Karim Saba, Bimal Bhindi, et al. 2020. “A Noninvasive Urine-Based Methylation Biomarker Panel to Detect Bladder Cancer and Discriminate Cancer Grade.” Urologic Oncology 38 (6): 603.e1-603.e7. doi:10.1016/j.urolonc.2020.01.007.